Related references
Note: Only part of the references are listed.Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy
Chaohui Wu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Serum MicroRNAs in HIV-Infected Individuals as Pre-Diagnosis Biomarkers for AIDS-NHL
Dharma R. Thapa et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Prognostic Role of MicroRNA-221 in Various Human Malignant Neoplasms: A Meta-Analysis of 20 Related Studies
Jie Yang et al.
PLOS ONE (2014)
Prognostic significance of microRNA-221/222 expression in cancers: evidence from 1,204 subjects
Jin Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer
Hui Cai et al.
MEDICAL ONCOLOGY (2013)
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
Cristina Quintavalle et al.
PLOS ONE (2013)
MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214
Anvesha Srivastava et al.
PLOS ONE (2013)
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls
Zhibin Hu et al.
CARCINOGENESIS (2012)
Analysis of serum genome-wide microRNAs for breast cancer detection
Qian Wu et al.
CLINICA CHIMICA ACTA (2012)
miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
M. Garofalo et al.
CURRENT MOLECULAR MEDICINE (2012)
Discriminating thyroid cancers from benign lesions based on differential expression of a limited set of miRNA using paraffin embedded tissues
Rekha Pai et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)
Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer
Apostolos Zaravinos et al.
JOURNAL OF UROLOGY (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status
Lingchao Chen et al.
ONCOLOGY REPORTS (2012)
Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer
Ming-yang Song et al.
PLOS ONE (2012)
Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
Peadar S. Waters et al.
PLOS ONE (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma
Ji Kon Ryu et al.
PANCREATOLOGY (2011)
Development of a MicroRNA-Based Molecular Assay for the Detection of Papillary Thyroid Carcinoma in Aspiration Biopsy Samples
Haggi Mazeh et al.
THYROID (2011)
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Fulya Yaman Agaoglu et al.
TUMOR BIOLOGY (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
Xing-xiang Pu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
The many roles of microRNAs in brain tumor biology
Jay D. Turner et al.
NEUROSURGICAL FOCUS (2010)
MicroRNAs in diagnosis and prognosis in cancer: what does the future hold?
Patrick Nana-Sinkam et al.
PHARMACOGENOMICS (2010)
The Molecular Machinery of Autophagy and its Role in Physiology and Disease and MicroRNAs in Animal Development
Stephen Cohen
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses
Dan Jackson et al.
STATISTICS IN MEDICINE (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
PTPμ suppresses glioma cell migration and dispersal
Adam M. Burgoyne et al.
NEURO-ONCOLOGY (2009)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1*
Silvia Galardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
JJ Deeks et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Comparison of BD Vacutainer SST™ Plus Tubes with BD SST™ II Plus Tubes for common analytes
VJ Bush et al.
CLINICA CHIMICA ACTA (2001)
Share Paper
